In this series of AUD patients with no decompensated liver disease admitted for hospital treatment of the disorder, plasma marker levels consistent with increased monocyte activation and increased systemic inflammation were associated with the presence of ALF, as were higher LBP levels. The gene discussed is LBP; the disease is liver disorder.